Xenon Reports Second Quarter 2025 Financial Results & Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Xenon Pharmaceuticals (XENE) Tops Q2 EPS by $2.06
August 11, 2025 4:04 PM EDTXenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of $1.07, $2.06 better than the analyst estimate of ($0.99).
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
... More